Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0027 Transporter Info | ||||
| Gene Name | SLC22A12 | ||||
| Protein Name | Urate anion exchanger 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs11231825 | ||||
| Site of GPD | chr11:64592802 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C | ||||
| Minor Allele Frequency | C=0.3860/1933 (Global) | ||||
| Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 4 Drugs in Total | ||||
| Cytarabine | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
| Fludarabine | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
| Gemtuzumab ozogamicin | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
| Idarubicin | Drug Info | Acute Myeloid Leukemia | Correlated with the increased likelihood of fever in patients (compare with genotypes CC + CT) | [ 1] | |
| References | |||||
| 1 | Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. Pharmacogenomics J. 2013 Aug;13(4):335-41. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.